FDA Inspection 1333028 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on Jul 31, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 31, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.